Search results
RSU 21 School Board election: Candidates emphasize communication at forum
Gannett via AOL· 4 hours agoMy hope is, if I were to remain on the board, that that would be my prime committee.” Kennedy-Smith,...
FDA confirms robotic prostatectomy survival rates match traditional surgery By Investing.com
Investing.com· 19 hours agoThe U.S. Food and Drug Administration (FDA) has approved a labeling revision for Intuitive's da...
Edwards Life Sciences sees positive results from TAVR trial
Medical Device Network via Yahoo Finance· 2 hours ago“These data are reassuring for patients and clinicians – particularly women who are more likely to...
Council Post: Embracing Advanced Tech In The Food And Beverage Industry, Part 3: Becoming...
Forbes· 2 days agoGary Iles is the senior vice president of marketing and business development at TraceGains. For food...
ASCO 2024: Alligator shares positive data for pancreatic cancer drug
Pharmaceutical Technology via Yahoo Finance· 2 days agoThe Sweden-headquartered company presented the Phase II readout at the American...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 6 days agoThis company, known for its relentless pursuit of quality survival products and comprehensive emergency preparedness solutions, offers an extensive array ...
Green hydrogen producer signs first-of-its-kind agreement with major steel company: 'Increasingly...
The Cool Down via Yahoo News· 6 days agoIt's exciting to see a leading steel company like Ugitech, which produces 220,000 tons of steel each...
TikTok influencers claim sunscreen is harmful. Here's why that's wrong, and dangerous
Daytona Beach News-Journal via Yahoo News· 3 hours agoBlack patients with melanoma have an estimated five-year melanoma survival rate of 70 percent,...
RNT Health Insights’ gastric cancer detection tool receives FDA BDD
Medical Device Network via Yahoo Finance· 3 days agoIndia-based clinical-stage medical diagnostics company RNT Health Insights has received breakthrough...
Bristol Myers Squibb’s Breyanzi shows promise in B-cell malignancy clinical trials
Clinical Trials Arena via Yahoo Finance· 2 days agoWith a median follow-up of 33.9 months, improvements were seen in event-free survival (EFS),...